Aptevo Therapeutics Inc.

Symbol: APVO

NASDAQ

0.7274

USD

Market price today

  • -0.0471

    P/E Ratio

  • 0.0029

    PEG Ratio

  • 0.49M

    MRK Cap

  • 0.00%

    DIV Yield

Aptevo Therapeutics Inc. (APVO) Stock Split, History Data

Working capital analysis

In terms of working capital, Aptevo Therapeutics Inc. maintains a healthy position. The total current assets of the company are valued at $19066000. This represents a growth rate of -30.543% compared to the previous year. Breaking down the current assets, the cash and investments are worth $16904000, exhibiting a growth rate of -25.319% year-on-year. The year-on-year growth rate for receivables is -100.000%. This represents a healthy year-on-year growth of -100.000% On the liabilities side, the company's current liabilities total $7224000. This reflects a growth rate of -17.023% over the previous year, indicating the company's financial obligations are well under control.

202320222021202020192018
Cash and investments
16.90
22.64
45.04
39.98
12.45
30.64
Receavebles
0.00
2.50
3.66
2.37
7.02
5.22
Inventory
0.00
1.57
3.08
4.78
6.14
1.78
Other
2.16
0.74
0.78
0.13
0.16
4.14
Total Current Assets
19.07
27.45
52.57
47.26
30.00
48.69
Acc Payable
3.98
3.50
3.46
5.58
13.04
11.67
Short Term Debt
0.00
2.00
11.67
5.00
19.86
0.00
Other Current Liab
3.24
6.71
23.09
9.54
9.08
5.94
Current Liabilities
7.22
8.71
34.76
14.54
38.24
17.61

Capital Structure

When examining the capital structure of Aptevo Therapeutics Inc., it is clear that the company manages a robust portfolio. These earnings represent the profits that Aptevo Therapeutics Inc. has chosen to reinvest in the business rather than distribute as dividends.

Total Assets

$NaN

Total liabilities

$NaN

Long term debt

$NaN

Cash and eqv

$NaN

Goodwill

$NaN

Retained earnings

$NaN

Common stock

$NaN

Enterprise Value

-$0.32

Frequently Asked Question

What is the latest historical split date of the company?

The latest historical split date is N/A.

What is firm free cah flow per share (FCF per share)?

The free cah flow per share (FCF per share) is -26.511.

What is company revenue per share?

The company revenue per share is 0.000.

What are firm earnings per share?

The firm earnings per share is 0.470.

What is Aptevo Therapeutics Inc. (APVO) ROIC (return on capital)?

Aptevo Therapeutics Inc. (APVO) ROIC (return on capital) is -1.639.

What is dividend per share figure?

The dividend per share is 0.000

What is enterprise plowback ratio?

Aptevo Therapeutics Inc. (APVO) plowback ratio is N/A

What is firm enterprise value (EV)?

The enterprise value (EV) is -0.318

What is company debt to equity ratio?

The debt to equity ratio is 0.442

What are debt ratio numbers?

The debt ratio is 0.217

What is company price to sales ratio?

The price to sales ratio is 0.000